Stand: E19
Altris AI, an artificial intelligence platform for OCT analysis, is used by more than 500 eye-care businesses worldwide. Unlike other solutions, which require a pre-existing assumption about a particular biomarker or a pathology, Altris AI identifies a wide range of retinal conditions (70+) without the need for targeted searches.
Altris AI now launches major updates before 100% Optical: Glaucoma Optic Disc Analysis module along with Fluids and Geographic Atrophy (GA) quantification and tracking functionalities.
Altris AI has introduced its Advanced Optic Disc (OD) Analysis, building on its earlier innovation with Ganglion Cell Complex (GCC) Asymmetry Analysis to enhance the improvements from the Altris AI macula module which has been available for several years.
The Advanced Glaucoma Analysis module has been created to address the challenges of both early glaucoma detection and the high rate of false positives in glaucoma screening.
